Hemoperfusion with Seraph-100 in septic patients removes pathogens and improves clinical outcomes

Abstract Hemoperfusion (HP) represents a treatment option for sepsis. This study evaluated Seraph-100 in septic patients admitted to the intensive care unit (ICU) after cardiac surgery due to infective endocarditis (IE). Thirteen septic patients were enrolled and treated by Seraph-100 hemoperfusion....

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Antonio Lacquaniti, Antonella Smeriglio, Fabrizio Ceresa, Susanna Campo, Daniele Caruso, Giuseppe Falliti, Erminia La Camera, Francesco Patané, Domenico Trombetta, Paolo Monardo
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Nature Portfolio 2025-05-01
Σειρά:	Scientific Reports
Θέματα:	Seraph-100 Hemoperfusion Sepsis AKI ICU stay
Διαθέσιμο Online:	https://doi.org/10.1038/s41598-025-01280-z
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!